The COVID-19 vaccines are a smash success. But that doesn’t mean they keep every vaccinated person completely free of the coronavirus.
Academic rigour, journalistic flair
Articles on COVID-19 vaccines
Displaying 281 - 300 of 576 articles
In the end, the best protection is mass vaccination and ensuring as many people as possible are fully vaccinated as quickly as possible.
Only about 1% of the population was vaccinated against COVID when this outbreak started.
Most shots work best when inserted into muscle. The shoulder muscle known as the deltoid works best.
Many over 50s seem to be asking this question. But there are a number of reasons it’s important to go ahead and get the AstraZeneca vaccine now.
Japan is going through its fourth wave, testing rates are low and case numbers are climbing. Now athletes aren’t happy with the IOC’s plans to protect them.
Community leaders or trusted work colleagues can be COVID vaccine advocates and help boost vaccination rates. Here are some simple steps they can take.
Sixteen countries authorised the use of Russia’s Sputnik V vaccine before phase 3 clinical trial results were published.
A public health expert outlines what Britons can expect from their upcoming booster programme.
Governments and companies are using incentives in hopes of getting more Americans to get a COVID-19 shot. A behavioral economist explains how they work.
Research has shown that vaccines have reduced infections, disease and hospitalisations – but will they continue to do so in the face of new variants?
Australians over 50 can get their AstraZeneca vaccine from a GP clinic from today. Here’s what you need to know when you book yourself in.
Full population-level protection against COVID-19 will require most adolescents and children to be vaccinated. There are ethical arguments for encouraging vaccination uptake through vaccine mandates.
Plus, the hidden world of microscopic fungi found inside the world’s biggest seed bank. Listen to episode 15 of The Conversation Weekly podcast.
A vaccine expert breaks down everything you need to know about Australia’s newest COVID-19 vaccine candidate.
Public officials are telling us simultaneously to move swiftly on vaccination and also to make thoughtful, reasoned choices about which vaccine we get. These messages are confusing and frustrating.
Waiver talks might convince companies to focus on technology transfer and training, and let go of the plan to maximise patent-based revenues.
Much remains to be resolved before the waiver is translated into increased vaccine supply.
You only have to prevent one case, which could have otherwise led to community spread and lockdown, for such a scheme to pay for itself many times over.
Canadian public health organizations have run into a serious communication problem about the AstraZeneca vaccine. Crisis management and communication theories explain what’s gone wrong.
Job Board
-
Project Offier - Diversity & Inclusion
-
Senior Lecturer - Earth System Science
-
Sydney Horizon Educators (Identified)
-
Deputy Social Media Producer
-
Associate Professor, Occupational Therapy
Top contributors
-
Associate professor, UNSW Sydney
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Early Career Research Leader, Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University
-
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute
-
Associate Professor, School of Social Sciences, The University of Western Australia
-
Associate Professor and ARC Future Fellow, The University of Western Australia
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Associate Professor, Epidemiology, Deakin University
-
Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
-
Assistant Professor of Political Science, Oklahoma State University
-
Instructor of Human Immunology, Emory University
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Immunology, Vice-Chancellors Distinguished Professorial Fellow, Head of Immunology and Translational Research, Victoria University
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Chair in Epidemiology, Deakin University
